Loading…
Human Bronchial Epithelial Cell Transcriptome Changes in Response to Serum from Patients with Different Status of Inflammation
Purpose To investigate the transcriptome of human bronchial epithelial cells (HBEC) in response to serum from patients with different degrees of inflammation. Methods Serum from 19 COVID-19 patients obtained from the Hannover Unified Biobank was used. At the time of sampling, 5 patients had a WHO Cl...
Saved in:
Published in: | Lung 2024-04, Vol.202 (2), p.157-170 |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c370t-7cdb2f6519da6c2976d430c2184d0ad01cf2508ab1bf3f9da2992544b18025b23 |
container_end_page | 170 |
container_issue | 2 |
container_start_page | 157 |
container_title | Lung |
container_volume | 202 |
creator | Sivaraman, Kokilavani Liu, Bin Martinez-Delgado, Beatriz Held, Julia Büttner, Manuela Illig, Thomas Volland, Sonja Gomez-Mariano, Gema Jedicke, Nils Yevsa, Tetyana Welte, Tobias DeLuca, David S. Wrenger, Sabine Olejnicka, Beata Janciauskiene, Sabina |
description | Purpose
To investigate the transcriptome of human bronchial epithelial cells (HBEC) in response to serum from patients with different degrees of inflammation.
Methods
Serum from 19 COVID-19 patients obtained from the Hannover Unified Biobank was used. At the time of sampling, 5 patients had a WHO Clinical Progression Scale (WHO-CPS) score of 9 (severe illness). The remaining 14 patients had a WHO-CPS of below 9 (range 1–7), and lower illness. Multiplex immunoassay was used to assess serum inflammatory markers. The culture medium of HBEC was supplemented with 2% of the patient’s serum, and the cells were cultured at 37 °C, 5% CO
2
for 18 h. Subsequently, cellular RNA was used for RNA-Seq.
Results
Patients with scores below 9 had significantly lower albumin and serum levels of E-selectin, IL-8, and MCP-1 than patients with scores of 9. Principal component analysis based on 500 “core genes” of RNA-seq segregated cells into two subsets: exposed to serum from 4 (I) and 15 (II) patients. Cells from a subset (I) treated with serum from 4 patients with a score of 9 showed 5566 differentially expressed genes of which 2793 were up- and 2773 downregulated in comparison with cells of subset II treated with serum from 14 patients with scores between 1 and 7 and one with score = 9. In subset I cells, a higher expression of
TLR4
and
CXCL8
but a lower
CDH1
,
ACE2
, and
HMOX1
, and greater effects on genes involved in metabolic regulation, cytoskeletal organization, and kinase activity pathways were observed.
Conclusion
This simple model could be useful to characterize patient serum and epithelial cell properties. |
doi_str_mv | 10.1007/s00408-024-00679-1 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2967058830</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2967058830</sourcerecordid><originalsourceid>FETCH-LOGICAL-c370t-7cdb2f6519da6c2976d430c2184d0ad01cf2508ab1bf3f9da2992544b18025b23</originalsourceid><addsrcrecordid>eNp9kU1vFSEUhonR2GvrH-iiIXHjZvTwMQOzrNdqmzTR2LomDAO90wwwBSbGjb9d2ttq4sIVkPOc9wAPQscE3hEA8T4DcJANUN4AdKJvyDO0IZzRhogWnqMNME4aWqED9CrnWwAiOtK-RAdM8p63VG7Qr_PV64A_pBjMbtIzPlumsrPz_XZr5xlfJx2ySdNSord4u9PhxmY8BfzN5iWGbHGJ-Mqm1WOXosdfdZlsKBn_qDn44-ScTfWMr4oua8bR4YvgZu195WI4Qi-cnrN9_bgeou-fzq63583ll88X29PLxjABpRFmHKjrWtKPujO0F93IGRhKJB9Bj0CMoy1IPZDBMVch2ve05XwgEmg7UHaI3u5zlxTvVpuL8lM29X062LhmRftOQCslg4q--Qe9jWsK9XaqVoVkvLKVonvKpJhzsk4tafI6_VQE1L0dtbejqh31YEeR2nTyGL0O3o5_Wp50VIDtgVxL9aPT39n_if0Nntma2w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3037834967</pqid></control><display><type>article</type><title>Human Bronchial Epithelial Cell Transcriptome Changes in Response to Serum from Patients with Different Status of Inflammation</title><source>Springer Link</source><creator>Sivaraman, Kokilavani ; Liu, Bin ; Martinez-Delgado, Beatriz ; Held, Julia ; Büttner, Manuela ; Illig, Thomas ; Volland, Sonja ; Gomez-Mariano, Gema ; Jedicke, Nils ; Yevsa, Tetyana ; Welte, Tobias ; DeLuca, David S. ; Wrenger, Sabine ; Olejnicka, Beata ; Janciauskiene, Sabina</creator><creatorcontrib>Sivaraman, Kokilavani ; Liu, Bin ; Martinez-Delgado, Beatriz ; Held, Julia ; Büttner, Manuela ; Illig, Thomas ; Volland, Sonja ; Gomez-Mariano, Gema ; Jedicke, Nils ; Yevsa, Tetyana ; Welte, Tobias ; DeLuca, David S. ; Wrenger, Sabine ; Olejnicka, Beata ; Janciauskiene, Sabina</creatorcontrib><description>Purpose
To investigate the transcriptome of human bronchial epithelial cells (HBEC) in response to serum from patients with different degrees of inflammation.
Methods
Serum from 19 COVID-19 patients obtained from the Hannover Unified Biobank was used. At the time of sampling, 5 patients had a WHO Clinical Progression Scale (WHO-CPS) score of 9 (severe illness). The remaining 14 patients had a WHO-CPS of below 9 (range 1–7), and lower illness. Multiplex immunoassay was used to assess serum inflammatory markers. The culture medium of HBEC was supplemented with 2% of the patient’s serum, and the cells were cultured at 37 °C, 5% CO
2
for 18 h. Subsequently, cellular RNA was used for RNA-Seq.
Results
Patients with scores below 9 had significantly lower albumin and serum levels of E-selectin, IL-8, and MCP-1 than patients with scores of 9. Principal component analysis based on 500 “core genes” of RNA-seq segregated cells into two subsets: exposed to serum from 4 (I) and 15 (II) patients. Cells from a subset (I) treated with serum from 4 patients with a score of 9 showed 5566 differentially expressed genes of which 2793 were up- and 2773 downregulated in comparison with cells of subset II treated with serum from 14 patients with scores between 1 and 7 and one with score = 9. In subset I cells, a higher expression of
TLR4
and
CXCL8
but a lower
CDH1
,
ACE2
, and
HMOX1
, and greater effects on genes involved in metabolic regulation, cytoskeletal organization, and kinase activity pathways were observed.
Conclusion
This simple model could be useful to characterize patient serum and epithelial cell properties.</description><identifier>ISSN: 0341-2040</identifier><identifier>ISSN: 1432-1750</identifier><identifier>EISSN: 1432-1750</identifier><identifier>DOI: 10.1007/s00408-024-00679-1</identifier><identifier>PMID: 38494528</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>ACE2 ; Angiotensin-converting enzyme 2 ; Biomarkers - metabolism ; Carbon dioxide ; Cell culture ; COVID-19 ; Cytoskeleton ; E-cadherin ; E-selectin ; Epithelial cells ; Epithelial Cells - metabolism ; Epithelium ; Gene regulation ; Genes ; Humans ; Illnesses ; Immunoassay ; Inflammation ; Inflammation - genetics ; Inflammation - metabolism ; Kinases ; Lung Inflammation ; Medicine ; Medicine & Public Health ; Monocyte chemoattractant protein 1 ; Patients ; Pneumology/Respiratory System ; Principal components analysis ; Ribonucleic acid ; RNA ; Serum levels ; TLR4 protein ; Toll-like receptors ; Transcriptome ; Transcriptomes</subject><ispartof>Lung, 2024-04, Vol.202 (2), p.157-170</ispartof><rights>The Author(s) 2024</rights><rights>2024. The Author(s).</rights><rights>The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c370t-7cdb2f6519da6c2976d430c2184d0ad01cf2508ab1bf3f9da2992544b18025b23</cites><orcidid>0000-0003-3228-8021 ; 0000-0002-9733-6162</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38494528$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sivaraman, Kokilavani</creatorcontrib><creatorcontrib>Liu, Bin</creatorcontrib><creatorcontrib>Martinez-Delgado, Beatriz</creatorcontrib><creatorcontrib>Held, Julia</creatorcontrib><creatorcontrib>Büttner, Manuela</creatorcontrib><creatorcontrib>Illig, Thomas</creatorcontrib><creatorcontrib>Volland, Sonja</creatorcontrib><creatorcontrib>Gomez-Mariano, Gema</creatorcontrib><creatorcontrib>Jedicke, Nils</creatorcontrib><creatorcontrib>Yevsa, Tetyana</creatorcontrib><creatorcontrib>Welte, Tobias</creatorcontrib><creatorcontrib>DeLuca, David S.</creatorcontrib><creatorcontrib>Wrenger, Sabine</creatorcontrib><creatorcontrib>Olejnicka, Beata</creatorcontrib><creatorcontrib>Janciauskiene, Sabina</creatorcontrib><title>Human Bronchial Epithelial Cell Transcriptome Changes in Response to Serum from Patients with Different Status of Inflammation</title><title>Lung</title><addtitle>Lung</addtitle><addtitle>Lung</addtitle><description>Purpose
To investigate the transcriptome of human bronchial epithelial cells (HBEC) in response to serum from patients with different degrees of inflammation.
Methods
Serum from 19 COVID-19 patients obtained from the Hannover Unified Biobank was used. At the time of sampling, 5 patients had a WHO Clinical Progression Scale (WHO-CPS) score of 9 (severe illness). The remaining 14 patients had a WHO-CPS of below 9 (range 1–7), and lower illness. Multiplex immunoassay was used to assess serum inflammatory markers. The culture medium of HBEC was supplemented with 2% of the patient’s serum, and the cells were cultured at 37 °C, 5% CO
2
for 18 h. Subsequently, cellular RNA was used for RNA-Seq.
Results
Patients with scores below 9 had significantly lower albumin and serum levels of E-selectin, IL-8, and MCP-1 than patients with scores of 9. Principal component analysis based on 500 “core genes” of RNA-seq segregated cells into two subsets: exposed to serum from 4 (I) and 15 (II) patients. Cells from a subset (I) treated with serum from 4 patients with a score of 9 showed 5566 differentially expressed genes of which 2793 were up- and 2773 downregulated in comparison with cells of subset II treated with serum from 14 patients with scores between 1 and 7 and one with score = 9. In subset I cells, a higher expression of
TLR4
and
CXCL8
but a lower
CDH1
,
ACE2
, and
HMOX1
, and greater effects on genes involved in metabolic regulation, cytoskeletal organization, and kinase activity pathways were observed.
Conclusion
This simple model could be useful to characterize patient serum and epithelial cell properties.</description><subject>ACE2</subject><subject>Angiotensin-converting enzyme 2</subject><subject>Biomarkers - metabolism</subject><subject>Carbon dioxide</subject><subject>Cell culture</subject><subject>COVID-19</subject><subject>Cytoskeleton</subject><subject>E-cadherin</subject><subject>E-selectin</subject><subject>Epithelial cells</subject><subject>Epithelial Cells - metabolism</subject><subject>Epithelium</subject><subject>Gene regulation</subject><subject>Genes</subject><subject>Humans</subject><subject>Illnesses</subject><subject>Immunoassay</subject><subject>Inflammation</subject><subject>Inflammation - genetics</subject><subject>Inflammation - metabolism</subject><subject>Kinases</subject><subject>Lung Inflammation</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Monocyte chemoattractant protein 1</subject><subject>Patients</subject><subject>Pneumology/Respiratory System</subject><subject>Principal components analysis</subject><subject>Ribonucleic acid</subject><subject>RNA</subject><subject>Serum levels</subject><subject>TLR4 protein</subject><subject>Toll-like receptors</subject><subject>Transcriptome</subject><subject>Transcriptomes</subject><issn>0341-2040</issn><issn>1432-1750</issn><issn>1432-1750</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kU1vFSEUhonR2GvrH-iiIXHjZvTwMQOzrNdqmzTR2LomDAO90wwwBSbGjb9d2ttq4sIVkPOc9wAPQscE3hEA8T4DcJANUN4AdKJvyDO0IZzRhogWnqMNME4aWqED9CrnWwAiOtK-RAdM8p63VG7Qr_PV64A_pBjMbtIzPlumsrPz_XZr5xlfJx2ySdNSord4u9PhxmY8BfzN5iWGbHGJ-Mqm1WOXosdfdZlsKBn_qDn44-ScTfWMr4oua8bR4YvgZu195WI4Qi-cnrN9_bgeou-fzq63583ll88X29PLxjABpRFmHKjrWtKPujO0F93IGRhKJB9Bj0CMoy1IPZDBMVch2ve05XwgEmg7UHaI3u5zlxTvVpuL8lM29X062LhmRftOQCslg4q--Qe9jWsK9XaqVoVkvLKVonvKpJhzsk4tafI6_VQE1L0dtbejqh31YEeR2nTyGL0O3o5_Wp50VIDtgVxL9aPT39n_if0Nntma2w</recordid><startdate>20240401</startdate><enddate>20240401</enddate><creator>Sivaraman, Kokilavani</creator><creator>Liu, Bin</creator><creator>Martinez-Delgado, Beatriz</creator><creator>Held, Julia</creator><creator>Büttner, Manuela</creator><creator>Illig, Thomas</creator><creator>Volland, Sonja</creator><creator>Gomez-Mariano, Gema</creator><creator>Jedicke, Nils</creator><creator>Yevsa, Tetyana</creator><creator>Welte, Tobias</creator><creator>DeLuca, David S.</creator><creator>Wrenger, Sabine</creator><creator>Olejnicka, Beata</creator><creator>Janciauskiene, Sabina</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3228-8021</orcidid><orcidid>https://orcid.org/0000-0002-9733-6162</orcidid></search><sort><creationdate>20240401</creationdate><title>Human Bronchial Epithelial Cell Transcriptome Changes in Response to Serum from Patients with Different Status of Inflammation</title><author>Sivaraman, Kokilavani ; Liu, Bin ; Martinez-Delgado, Beatriz ; Held, Julia ; Büttner, Manuela ; Illig, Thomas ; Volland, Sonja ; Gomez-Mariano, Gema ; Jedicke, Nils ; Yevsa, Tetyana ; Welte, Tobias ; DeLuca, David S. ; Wrenger, Sabine ; Olejnicka, Beata ; Janciauskiene, Sabina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c370t-7cdb2f6519da6c2976d430c2184d0ad01cf2508ab1bf3f9da2992544b18025b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>ACE2</topic><topic>Angiotensin-converting enzyme 2</topic><topic>Biomarkers - metabolism</topic><topic>Carbon dioxide</topic><topic>Cell culture</topic><topic>COVID-19</topic><topic>Cytoskeleton</topic><topic>E-cadherin</topic><topic>E-selectin</topic><topic>Epithelial cells</topic><topic>Epithelial Cells - metabolism</topic><topic>Epithelium</topic><topic>Gene regulation</topic><topic>Genes</topic><topic>Humans</topic><topic>Illnesses</topic><topic>Immunoassay</topic><topic>Inflammation</topic><topic>Inflammation - genetics</topic><topic>Inflammation - metabolism</topic><topic>Kinases</topic><topic>Lung Inflammation</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Monocyte chemoattractant protein 1</topic><topic>Patients</topic><topic>Pneumology/Respiratory System</topic><topic>Principal components analysis</topic><topic>Ribonucleic acid</topic><topic>RNA</topic><topic>Serum levels</topic><topic>TLR4 protein</topic><topic>Toll-like receptors</topic><topic>Transcriptome</topic><topic>Transcriptomes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sivaraman, Kokilavani</creatorcontrib><creatorcontrib>Liu, Bin</creatorcontrib><creatorcontrib>Martinez-Delgado, Beatriz</creatorcontrib><creatorcontrib>Held, Julia</creatorcontrib><creatorcontrib>Büttner, Manuela</creatorcontrib><creatorcontrib>Illig, Thomas</creatorcontrib><creatorcontrib>Volland, Sonja</creatorcontrib><creatorcontrib>Gomez-Mariano, Gema</creatorcontrib><creatorcontrib>Jedicke, Nils</creatorcontrib><creatorcontrib>Yevsa, Tetyana</creatorcontrib><creatorcontrib>Welte, Tobias</creatorcontrib><creatorcontrib>DeLuca, David S.</creatorcontrib><creatorcontrib>Wrenger, Sabine</creatorcontrib><creatorcontrib>Olejnicka, Beata</creatorcontrib><creatorcontrib>Janciauskiene, Sabina</creatorcontrib><collection>Springer_OA刊</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Lung</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sivaraman, Kokilavani</au><au>Liu, Bin</au><au>Martinez-Delgado, Beatriz</au><au>Held, Julia</au><au>Büttner, Manuela</au><au>Illig, Thomas</au><au>Volland, Sonja</au><au>Gomez-Mariano, Gema</au><au>Jedicke, Nils</au><au>Yevsa, Tetyana</au><au>Welte, Tobias</au><au>DeLuca, David S.</au><au>Wrenger, Sabine</au><au>Olejnicka, Beata</au><au>Janciauskiene, Sabina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Human Bronchial Epithelial Cell Transcriptome Changes in Response to Serum from Patients with Different Status of Inflammation</atitle><jtitle>Lung</jtitle><stitle>Lung</stitle><addtitle>Lung</addtitle><date>2024-04-01</date><risdate>2024</risdate><volume>202</volume><issue>2</issue><spage>157</spage><epage>170</epage><pages>157-170</pages><issn>0341-2040</issn><issn>1432-1750</issn><eissn>1432-1750</eissn><abstract>Purpose
To investigate the transcriptome of human bronchial epithelial cells (HBEC) in response to serum from patients with different degrees of inflammation.
Methods
Serum from 19 COVID-19 patients obtained from the Hannover Unified Biobank was used. At the time of sampling, 5 patients had a WHO Clinical Progression Scale (WHO-CPS) score of 9 (severe illness). The remaining 14 patients had a WHO-CPS of below 9 (range 1–7), and lower illness. Multiplex immunoassay was used to assess serum inflammatory markers. The culture medium of HBEC was supplemented with 2% of the patient’s serum, and the cells were cultured at 37 °C, 5% CO
2
for 18 h. Subsequently, cellular RNA was used for RNA-Seq.
Results
Patients with scores below 9 had significantly lower albumin and serum levels of E-selectin, IL-8, and MCP-1 than patients with scores of 9. Principal component analysis based on 500 “core genes” of RNA-seq segregated cells into two subsets: exposed to serum from 4 (I) and 15 (II) patients. Cells from a subset (I) treated with serum from 4 patients with a score of 9 showed 5566 differentially expressed genes of which 2793 were up- and 2773 downregulated in comparison with cells of subset II treated with serum from 14 patients with scores between 1 and 7 and one with score = 9. In subset I cells, a higher expression of
TLR4
and
CXCL8
but a lower
CDH1
,
ACE2
, and
HMOX1
, and greater effects on genes involved in metabolic regulation, cytoskeletal organization, and kinase activity pathways were observed.
Conclusion
This simple model could be useful to characterize patient serum and epithelial cell properties.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>38494528</pmid><doi>10.1007/s00408-024-00679-1</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0003-3228-8021</orcidid><orcidid>https://orcid.org/0000-0002-9733-6162</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0341-2040 |
ispartof | Lung, 2024-04, Vol.202 (2), p.157-170 |
issn | 0341-2040 1432-1750 1432-1750 |
language | eng |
recordid | cdi_proquest_miscellaneous_2967058830 |
source | Springer Link |
subjects | ACE2 Angiotensin-converting enzyme 2 Biomarkers - metabolism Carbon dioxide Cell culture COVID-19 Cytoskeleton E-cadherin E-selectin Epithelial cells Epithelial Cells - metabolism Epithelium Gene regulation Genes Humans Illnesses Immunoassay Inflammation Inflammation - genetics Inflammation - metabolism Kinases Lung Inflammation Medicine Medicine & Public Health Monocyte chemoattractant protein 1 Patients Pneumology/Respiratory System Principal components analysis Ribonucleic acid RNA Serum levels TLR4 protein Toll-like receptors Transcriptome Transcriptomes |
title | Human Bronchial Epithelial Cell Transcriptome Changes in Response to Serum from Patients with Different Status of Inflammation |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T07%3A25%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Human%20Bronchial%20Epithelial%20Cell%20Transcriptome%20Changes%20in%20Response%20to%20Serum%20from%20Patients%20with%20Different%20Status%20of%20Inflammation&rft.jtitle=Lung&rft.au=Sivaraman,%20Kokilavani&rft.date=2024-04-01&rft.volume=202&rft.issue=2&rft.spage=157&rft.epage=170&rft.pages=157-170&rft.issn=0341-2040&rft.eissn=1432-1750&rft_id=info:doi/10.1007/s00408-024-00679-1&rft_dat=%3Cproquest_cross%3E2967058830%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c370t-7cdb2f6519da6c2976d430c2184d0ad01cf2508ab1bf3f9da2992544b18025b23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3037834967&rft_id=info:pmid/38494528&rfr_iscdi=true |